Of therapeutic relevance, PSTG2 (COX-2) inhibitor celecoxib was found to lower FN1 and COL1 expression and attenuate the vessel wall thickness in stroke-prone spontaneously hypertensive rats (Tang et al., 2015). Here, FN1 is linked to Stroke.